by Harriet Boyd | Feb 2022 | VHH Resources
Using synthetic VHH to optimize T-cell mediated immunotherapies The potential of T-cell engaging VHH single-domain therapeutics This webinar summarises the clinical and research landscape for CAR-T and T-cell engaging antibody therapies and show how single domain VHH... by Harriet Boyd | Aug 2021 | VHH Resources, VHHs
Optimizing CAR-T and T-cell antibody engagers: a role for VHH single domain antibodies read our whitepaper " Clinical landscape and applications of single domain VHH antibodies for optimisation of next generation T-cell immunodirection therapies Learnings from...